ONTOLOGY REPORT - ANNOTATIONS
| Term: | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
|
| Accession: | CHEBI:17963
|
browse the term
|
| Definition: | A phenylpyridine that has formula C12H15N. |
| Synonyms: | related_synonym: | C12H15N; CN1CCC(=CC1)c1ccccc1; InChI=1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3; InChIKey=PLRACCBDVIHHLZ-UHFFFAOYSA-N; MPTP |
| | alt_id: | CHEBI:11263; CHEBI:19059; CHEBI:639 |
| | xref_casrn: | 28289-54-5 |
| | xref: | ChEMBL:130630 "ChEMBL COMPOUND"; CiteXplore:21798732 "PubMed citation"; CiteXplore:21830164 "PubMed citation"; CiteXplore:22393538 "PubMed citation"; CiteXplore:23296790 "PubMed citation"; KEGG COMPOUND:28289-54-5 "CAS Registry Number"; KEGG COMPOUND:C04599 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D015632 |
|
|
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
|
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
decreases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
decreases expression |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Acaa2 |
acetyl-CoA acyltransferase 2 |
|
multiple interactions |
ISO |
18 |
71,587,259 |
71,632,610 |
RGD:6480464 |
CTD |
| G |
Actr1a |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
increases expression |
ISO |
1 |
251,592,429 |
251,611,097 |
RGD:6480464 |
CTD |
| G |
Actr1a |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
|
multiple interactions |
ISO |
1 |
251,592,429 |
251,611,097 |
RGD:6480464 |
CTD |
| G |
Adck3 |
aarF domain containing kinase 3 |
|
multiple interactions |
ISO |
13 |
95,869,376 |
95,896,742 |
RGD:6480464 |
CTD |
| G |
Adck3 |
aarF domain containing kinase 3 |
|
decreases expression |
ISO |
13 |
95,869,376 |
95,896,742 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
decreases expression |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
multiple interactions |
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:6480464 |
CTD |
| G |
Adnp |
activity-dependent neuroprotector homeobox |
|
decreases expression |
ISO |
3 |
159,345,280 |
159,355,067 |
RGD:6480464 |
CTD |
| G |
Adnp |
activity-dependent neuroprotector homeobox |
|
multiple interactions |
ISO |
3 |
159,345,280 |
159,355,067 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
increases expression |
ISO |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
multiple interactions |
ISO |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
decreases expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
multiple interactions |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Api5 |
apoptosis inhibitor 5 |
|
decreases expression |
ISO |
3 |
78,819,632 |
78,844,710 |
RGD:6480464 |
CTD |
| G |
Api5 |
apoptosis inhibitor 5 |
|
multiple interactions |
ISO |
3 |
78,819,632 |
78,844,710 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
decreases expression |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arf3 |
ADP-ribosylation factor 3 |
|
decreases expression |
ISO |
7 |
137,505,200 |
137,510,262 |
RGD:6480464 |
CTD |
| G |
Arf3 |
ADP-ribosylation factor 3 |
|
multiple interactions |
ISO |
7 |
137,505,200 |
137,510,262 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
decreases expression |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Aspm |
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) |
|
multiple interactions |
ISO |
13 |
52,811,658 |
52,860,925 |
RGD:6480464 |
CTD |
| G |
Atp6v0a4 |
ATPase, H+ transporting, lysosomal V0 subunit A4 |
|
decreases expression |
ISO |
4 |
65,588,970 |
65,671,150 |
RGD:6480464 |
CTD |
| G |
Atp6v0a4 |
ATPase, H+ transporting, lysosomal V0 subunit A4 |
|
multiple interactions |
ISO |
4 |
65,588,970 |
65,671,150 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
decreases expression |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
multiple interactions |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
decreases expression |
ISO |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
multiple interactions |
ISO |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp9a |
ATPase, class II, type 9A |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp9a |
ATPase, class II, type 9A |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atrn |
attractin |
|
increases expression |
ISO |
3 |
118,539,268 |
118,701,177 |
RGD:6480464 |
CTD |
| G |
Atrn |
attractin |
|
multiple interactions |
ISO |
3 |
118,539,268 |
118,701,177 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
increases expression |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Bap1 |
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) |
|
multiple interactions |
ISO |
16 |
6,684,470 |
6,693,296 |
RGD:6480464 |
CTD |
| G |
Bcl2l10 |
BCL2-like 10 (apoptosis facilitator) |
|
decreases expression |
ISO |
8 |
80,172,804 |
80,178,851 |
RGD:6480464 |
CTD |
| G |
Bcl2l10 |
BCL2-like 10 (apoptosis facilitator) |
|
multiple interactions |
ISO |
8 |
80,172,804 |
80,178,851 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
increases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
increases expression |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C1r |
complement component 1, r subcomponent |
|
multiple interactions |
ISO |
4 |
160,712,582 |
160,729,362 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
increases expression |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
multiple interactions |
ISO |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
multiple interactions |
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
increases expression |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp12 |
caspase 12 |
|
multiple interactions |
ISO |
8 |
2,082,933 |
2,110,511 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases expression |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
multiple interactions |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
increases expression |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
increases expression |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
multiple interactions |
ISO |
4 |
163,523,817 |
163,546,501 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
multiple interactions |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
decreases expression |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
increases expression |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
multiple interactions |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
increases expression |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
multiple interactions |
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
multiple interactions |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cetn3 |
centrin, EF-hand protein, 3 |
|
increases expression |
ISO |
2 |
9,909,950 |
9,922,361 |
RGD:6480464 |
CTD |
| G |
Cetn3 |
centrin, EF-hand protein, 3 |
|
multiple interactions |
ISO |
2 |
9,909,950 |
9,922,361 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
increases expression |
ISO |
1 |
136,031,865 |
136,045,153 |
RGD:6480464 |
CTD |
| G |
Cib1 |
calcium and integrin binding 1 (calmyrin) |
|
multiple interactions |
ISO |
1 |
136,031,865 |
136,045,153 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
multiple interactions |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
increases expression |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
multiple interactions |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
decreases expression |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
multiple interactions |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clca2 |
chloride channel accessory 2 |
|
decreases expression |
ISO |
2 |
243,114,775 |
243,142,349 |
RGD:6480464 |
CTD |
| G |
Clstn1 |
calsyntenin 1 |
|
multiple interactions |
ISO |
5 |
166,671,098 |
166,734,907 |
RGD:6480464 |
CTD |
| G |
Clstn1 |
calsyntenin 1 |
|
decreases expression |
ISO |
5 |
166,671,098 |
166,734,907 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
increases expression |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
multiple interactions |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Cox7a2l |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
decreases expression |
ISO |
6 |
6,834,523 |
6,861,652 |
RGD:6480464 |
CTD |
| G |
Cox7a2l |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
|
multiple interactions |
ISO |
6 |
6,834,523 |
6,861,652 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
decreases expression |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cox7c |
cytochrome c oxidase, subunit VIIc |
|
multiple interactions |
ISO |
2 |
15,254,040 |
15,256,065 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
decreases expression |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
multiple interactions |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
increases metabolic processing |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases metabolic processing |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Dcxr |
dicarbonyl L-xylulose reductase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
increases expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dnajb9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
multiple interactions |
ISO |
6 |
63,583,033 |
63,587,247 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
increases expression |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
multiple interactions |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
multiple interactions |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Ecm1 |
extracellular matrix protein 1 |
|
decreases expression |
ISO |
2 |
190,525,156 |
190,530,323 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
increases expression |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef1a1 |
eukaryotic translation elongation factor 1 alpha 1 |
|
multiple interactions |
ISO |
8 |
83,463,591 |
83,466,813 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
increases expression |
ISO |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
ISO |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
decreases expression |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
multiple interactions |
ISO |
2 |
181,444,599 |
181,451,944 |
RGD:6480464 |
CTD |
| G |
Efnb3 |
ephrin B3 |
|
increases expression |
ISO |
10 |
56,373,322 |
56,379,316 |
RGD:6480464 |
CTD |
| G |
Efnb3 |
ephrin B3 |
|
multiple interactions |
ISO |
10 |
56,373,322 |
56,379,316 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
decreases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
affects phosphorylation |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
affects phosphorylation |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
decreases expression |
ISO |
6 |
25,159,823 |
25,165,561 |
RGD:6480464 |
CTD |
| G |
Eif2b4 |
eukaryotic translation initiation factor 2B, subunit 4 delta |
|
multiple interactions |
ISO |
6 |
25,159,823 |
25,165,561 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
multiple interactions |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
decreases expression |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
increases expression |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
En1 |
engrailed homeobox 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
En2 |
engrailed homeobox 2 |
|
multiple interactions |
ISO |
4 |
2,469,889 |
2,475,729 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
decreases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
decreases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
multiple interactions |
ISO |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
increases expression |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions |
ISO |
10 |
95,794,488 |
95,855,895 |
RGD:6480464 |
CTD |
| G |
Erp44 |
endoplasmic reticulum protein 44 |
|
increases expression |
ISO |
5 |
64,869,536 |
64,962,569 |
RGD:6480464 |
CTD |
| G |
Erp44 |
endoplasmic reticulum protein 44 |
|
multiple interactions |
ISO |
5 |
64,869,536 |
64,962,569 |
RGD:6480464 |
CTD |
| G |
Etfa |
electron-transfer-flavoprotein, alpha polypeptide |
|
decreases expression |
ISO |
8 |
59,013,798 |
59,072,013 |
RGD:6480464 |
CTD |
| G |
Etfa |
electron-transfer-flavoprotein, alpha polypeptide |
|
multiple interactions |
ISO |
8 |
59,013,798 |
59,072,013 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
multiple interactions |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
decreases expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Fbxl12 |
F-box and leucine-rich repeat protein 12 |
|
multiple interactions |
ISO |
8 |
19,656,937 |
19,661,560 |
RGD:6480464 |
CTD |
| G |
Fbxl12 |
F-box and leucine-rich repeat protein 12 |
|
decreases expression |
ISO |
8 |
19,656,937 |
19,661,560 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
multiple interactions |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
decreases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
increases expression |
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:6480464 |
CTD |
| G |
Gab1 |
GRB2-associated binding protein 1 |
|
multiple interactions |
ISO |
19 |
28,980,284 |
29,088,877 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
increases expression |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
multiple interactions |
ISO |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
multiple interactions |
ISO |
18 |
2,504,264 |
2,534,648 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
decreases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
decreases expression |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Ghitm |
growth hormone inducible transmembrane protein |
|
multiple interactions |
ISO |
16 |
13,327,337 |
13,338,420 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
increases expression |
ISO |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
multiple interactions |
ISO |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
decreases expression |
ISO |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
multiple interactions |
ISO |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Golt1b |
golgi transport 1B |
|
increases expression |
ISO |
4 |
179,952,033 |
179,963,246 |
RGD:6480464 |
CTD |
| G |
Golt1b |
golgi transport 1B |
|
multiple interactions |
ISO |
4 |
179,952,033 |
179,963,246 |
RGD:6480464 |
CTD |
| G |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
|
increases expression |
ISO |
10 |
104,731,909 |
104,754,468 |
RGD:6480464 |
CTD |
| G |
Gprc5c |
G protein-coupled receptor, family C, group 5, member C |
|
multiple interactions |
ISO |
10 |
104,731,909 |
104,754,468 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
increases expression |
ISO |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Grid2 |
glutamate receptor, ionotropic, delta 2 |
|
multiple interactions |
ISO |
4 |
92,642,427 |
94,054,757 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
increases expression |
ISO |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Gstm6 |
glutathione S-transferase, mu 6 |
|
multiple interactions |
ISO |
2 |
203,504,228 |
203,509,002 |
RGD:6480464 |
CTD |
| G |
Hba2 |
hemoglobin, alpha 2 |
|
decreases expression |
ISO |
10 |
15,570,930 |
15,571,773 |
RGD:6480464 |
CTD |
| G |
Hba2 |
hemoglobin, alpha 2 |
|
multiple interactions |
ISO |
10 |
15,570,930 |
15,571,773 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
multiple interactions |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hells |
helicase, lymphoid specific |
|
increases expression |
ISO |
1 |
243,246,843 |
243,262,459 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
multiple interactions |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
increases expression |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hipk1 |
homeodomain interacting protein kinase 1 |
|
increases expression |
ISO |
2 |
198,963,076 |
199,014,710 |
RGD:6480464 |
CTD |
| G |
Hipk1 |
homeodomain interacting protein kinase 1 |
|
multiple interactions |
ISO |
2 |
198,963,076 |
199,014,710 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
decreases expression |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
ISO |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
decreases expression |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
EXP |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
multiple interactions |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
increases expression |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
multiple interactions |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Irx3 |
iroquois homeobox 3 |
|
multiple interactions |
ISO |
19 |
16,345,179 |
16,347,455 |
RGD:6480464 |
CTD |
| G |
Irx3 |
iroquois homeobox 3 |
|
decreases expression |
ISO |
19 |
16,345,179 |
16,347,455 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
decreases expression |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Itm2b |
integral membrane protein 2B |
|
multiple interactions |
ISO |
15 |
54,005,134 |
54,028,036 |
RGD:6480464 |
CTD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
increases expression |
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:6480464 |
CTD |
| G |
Jmjd6 |
jumonji domain containing 6 |
|
multiple interactions |
ISO |
10 |
106,942,942 |
106,948,652 |
RGD:6480464 |
CTD |
| G |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
|
affects response to substance |
ISO |
11 |
35,025,118 |
35,116,500 |
RGD:6480464 |
CTD |
| G |
Kif3b |
kinesin family member 3B |
|
decreases expression |
ISO |
3 |
143,642,175 |
143,681,902 |
RGD:6480464 |
CTD |
| G |
Kif3b |
kinesin family member 3B |
|
multiple interactions |
ISO |
3 |
143,642,175 |
143,681,902 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
multiple interactions |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Leprel2 |
leprecan-like 2 |
|
multiple interactions |
ISO |
4 |
160,964,297 |
160,978,321 |
RGD:6480464 |
CTD |
| G |
Leprel2 |
leprecan-like 2 |
|
increases expression |
ISO |
4 |
160,964,297 |
160,978,321 |
RGD:6480464 |
CTD |
| G |
Lpar4 |
lysophosphatidic acid receptor 4 |
|
decreases expression |
ISO |
X |
95,180,476 |
95,194,380 |
RGD:6480464 |
CTD |
| G |
Lpar4 |
lysophosphatidic acid receptor 4 |
|
multiple interactions |
ISO |
X |
95,180,476 |
95,194,380 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
increases expression |
ISO |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
ISO |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
increases expression |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
multiple interactions |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
increases metabolic processing |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
increases oxidation |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
multiple interactions |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
increases expression |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
increases expression |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
multiple interactions |
ISO |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mc2r |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
decreases expression |
ISO |
18 |
64,591,344 |
64,601,883 |
RGD:6480464 |
CTD |
| G |
Mc2r |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
multiple interactions |
ISO |
18 |
64,591,344 |
64,601,883 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
decreases expression |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Me1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
|
multiple interactions |
ISO |
8 |
91,839,845 |
91,955,917 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
multiple interactions |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mrpl10 |
mitochondrial ribosomal protein L10 |
|
decreases expression |
ISO |
10 |
85,761,934 |
85,770,350 |
RGD:6480464 |
CTD |
| G |
Mrpl10 |
mitochondrial ribosomal protein L10 |
|
multiple interactions |
ISO |
10 |
85,761,934 |
85,770,350 |
RGD:6480464 |
CTD |
| G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
|
decreases expression |
ISO |
5 |
172,657,923 |
172,662,453 |
RGD:6480464 |
CTD |
| G |
Mrpl20 |
mitochondrial ribosomal protein L20 |
|
multiple interactions |
ISO |
5 |
172,657,923 |
172,662,453 |
RGD:6480464 |
CTD |
| G |
mrpl9 |
mitochondrial ribosomal protein L9 |
|
increases expression |
ISO |
2 |
189,417,391 |
189,422,111 |
RGD:6480464 |
CTD |
| G |
mrpl9 |
mitochondrial ribosomal protein L9 |
|
multiple interactions |
ISO |
2 |
189,417,391 |
189,422,111 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mtch1 |
mitochondrial carrier 1 |
|
increases expression |
ISO |
20 |
7,649,782 |
7,673,289 |
RGD:6480464 |
CTD |
| G |
Mtch1 |
mitochondrial carrier 1 |
|
multiple interactions |
ISO |
20 |
7,649,782 |
7,673,289 |
RGD:6480464 |
CTD |
| G |
Mtf2 |
metal response element binding transcription factor 2 |
|
multiple interactions |
ISO |
14 |
2,189,596 |
2,232,660 |
RGD:6480464 |
CTD |
| G |
Mtf2 |
metal response element binding transcription factor 2 |
|
increases expression |
ISO |
14 |
2,189,596 |
2,232,660 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
affects phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
decreases expression |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufb5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 |
|
multiple interactions |
ISO |
2 |
118,946,438 |
118,963,186 |
RGD:6480464 |
CTD |
| G |
Ndufs1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1 |
|
multiple interactions |
ISO |
9 |
61,798,141 |
61,831,964 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
decreases expression |
ISO |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Ndufs4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4 |
|
multiple interactions |
ISO |
2 |
45,839,236 |
46,479,619 |
RGD:6480464 |
CTD |
| G |
Ngb |
neuroglobin |
|
decreases expression |
ISO |
6 |
111,231,188 |
111,236,255 |
RGD:6480464 |
CTD |
| G |
Ngb |
neuroglobin |
|
multiple interactions |
ISO |
6 |
111,231,188 |
111,236,255 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
increases expression |
ISO |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases activity |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
multiple interactions |
ISO |
13 |
68,524,023 |
68,567,312 |
RGD:6480464 |
CTD |
| G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
decreases expression |
ISO |
13 |
68,524,023 |
68,567,312 |
RGD:6480464 |
CTD |
| G |
Nrf1 |
nuclear respiratory factor 1 |
|
decreases expression |
ISO |
4 |
56,949,553 |
57,048,149 |
RGD:6480464 |
CTD |
| G |
Nsf |
N-ethylmaleimide-sensitive factor |
|
increases expression |
ISO |
10 |
92,974,385 |
93,082,222 |
RGD:6480464 |
CTD |
| G |
Nsf |
N-ethylmaleimide-sensitive factor |
|
multiple interactions |
ISO |
10 |
92,974,385 |
93,082,222 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
multiple interactions |
ISO |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
increases expression |
ISO |
11 |
70,529,961 |
70,588,511 |
RGD:6480464 |
CTD |
| G |
Pak2 |
p21 protein (Cdc42/Rac)-activated kinase 2 |
|
multiple interactions |
ISO |
11 |
70,529,961 |
70,588,511 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
decreases response to substance |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
increases expression |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
multiple interactions |
ISO |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase family A, member 6 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Pfdn1 |
prefoldin subunit 1 |
|
increases expression |
ISO |
18 |
29,043,386 |
29,096,475 |
RGD:6480464 |
CTD |
| G |
Pfdn1 |
prefoldin subunit 1 |
|
multiple interactions |
ISO |
18 |
29,043,386 |
29,096,475 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
decreases expression |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
multiple interactions |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
increases expression |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Pidd |
p53-induced death domain protein |
|
multiple interactions |
ISO |
1 |
201,626,042 |
201,631,182 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
increases expression |
ISO |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pigc |
phosphatidylinositol glycan anchor biosynthesis, class C |
|
multiple interactions |
ISO |
13 |
77,664,442 |
77,666,797 |
RGD:6480464 |
CTD |
| G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
multiple interactions |
ISO |
8 |
19,669,537 |
19,681,741 |
RGD:6480464 |
CTD |
| G |
Pin1 |
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 |
|
increases expression |
ISO |
8 |
19,669,537 |
19,681,741 |
RGD:6480464 |
CTD |
| G |
Pip5k1c |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
|
increases expression |
ISO |
7 |
9,881,767 |
9,909,651 |
RGD:6480464 |
CTD |
| G |
Pip5k1c |
phosphatidylinositol-4-phosphate 5-kinase, type I, gamma |
|
multiple interactions |
ISO |
7 |
9,881,767 |
9,909,651 |
RGD:6480464 |
CTD |
| G |
Plaa |
phospholipase A2, activating protein |
|
increases expression |
ISO |
5 |
114,869,341 |
114,899,356 |
RGD:6480464 |
CTD |
| G |
Plaa |
phospholipase A2, activating protein |
|
multiple interactions |
ISO |
5 |
114,869,341 |
114,899,356 |
RGD:6480464 |
CTD |
| G |
Pnoc |
prepronociceptin |
|
affects response to substance |
ISO |
15 |
44,822,635 |
44,835,637 |
RGD:6480464 |
CTD |
| G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
|
increases expression |
ISO |
6 |
63,644,462 |
63,676,544 |
RGD:6480464 |
CTD |
| G |
Pnpla8 |
patatin-like phospholipase domain containing 8 |
|
multiple interactions |
ISO |
6 |
63,644,462 |
63,676,544 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
decreases expression |
ISO |
6 |
8,319,544 |
8,373,795 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase, Mg2+/Mn2+ dependent, 1B |
|
multiple interactions |
ISO |
6 |
8,319,544 |
8,373,795 |
RGD:6480464 |
CTD |
| G |
Ppp2r3c |
protein phosphatase 2, regulatory subunit B'', gamma |
|
increases expression |
ISO |
6 |
75,516,505 |
75,539,654 |
RGD:6480464 |
CTD |
| G |
Ppp2r3c |
protein phosphatase 2, regulatory subunit B'', gamma |
|
multiple interactions |
ISO |
6 |
75,516,505 |
75,539,654 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
increases expression |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prdx3 |
peroxiredoxin 3 |
|
multiple interactions |
ISO |
1 |
267,468,371 |
267,481,273 |
RGD:6480464 |
CTD |
| G |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
|
multiple interactions |
ISO |
12 |
41,840,866 |
41,851,241 |
RGD:6480464 |
CTD |
| G |
Prkab1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
|
decreases expression |
ISO |
12 |
41,840,866 |
41,851,241 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
decreases expression |
ISO |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
multiple interactions |
ISO |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
decreases expression |
ISO |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
multiple interactions |
ISO |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmg2 |
proteasome (prosome, macropain) assembly chaperone 2 |
|
increases expression |
ISO |
18 |
64,185,650 |
64,200,223 |
RGD:6480464 |
CTD |
| G |
Psmg2 |
proteasome (prosome, macropain) assembly chaperone 2 |
|
multiple interactions |
ISO |
18 |
64,185,650 |
64,200,223 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
increases expression |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Pycard |
PYD and CARD domain containing |
|
multiple interactions |
ISO |
1 |
187,276,089 |
187,277,122 |
RGD:6480464 |
CTD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
multiple interactions |
ISO |
16 |
19,189,765 |
19,193,874 |
RGD:6480464 |
CTD |
| G |
Rab5a |
RAB5A, member RAS oncogene family |
|
multiple interactions |
ISO |
9 |
1,492,864 |
1,516,405 |
RGD:6480464 |
CTD |
| G |
Rab5a |
RAB5A, member RAS oncogene family |
|
multiple interactions |
ISO |
9 |
1,492,864 |
1,516,405 |
RGD:6480464 |
CTD |
| G |
Rab5al1 |
Rab5a, member RAS oncogene family-like 1 |
|
multiple interactions |
ISO |
14 |
73,512,120 |
73,515,650 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
decreases expression |
ISO |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Rab7a |
RAB7A, member RAS oncogene family |
|
multiple interactions |
ISO |
4 |
122,202,685 |
122,220,649 |
RGD:6480464 |
CTD |
| G |
Rab8a |
RAB8A, member RAS oncogene family |
|
multiple interactions |
ISO |
16 |
18,078,519 |
18,099,882 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
increases expression |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad1 |
RAD1 homolog (S. pombe) |
|
multiple interactions |
ISO |
2 |
59,837,934 |
59,845,973 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rad50 |
RAD50 homolog (S. cerevisiae) |
|
increases expression |
ISO |
10 |
39,112,733 |
39,164,694 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
increases expression |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
increases expression |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rasa3 |
RAS p21 protein activator 3 |
|
multiple interactions |
ISO |
16 |
80,710,463 |
80,824,220 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
multiple interactions |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbbp4 |
retinoblastoma binding protein 4 |
|
decreases expression |
ISO |
5 |
148,472,397 |
148,492,172 |
RGD:6480464 |
CTD |
| G |
Rbbp5 |
retinoblastoma binding protein 5 |
|
increases expression |
ISO |
13 |
45,364,906 |
45,391,757 |
RGD:6480464 |
CTD |
| G |
Rbbp5 |
retinoblastoma binding protein 5 |
|
multiple interactions |
ISO |
13 |
45,364,906 |
45,391,757 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases expression |
ISO |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
decreases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
multiple interactions |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rpl26 |
ribosomal protein L26 |
|
multiple interactions |
ISO |
10 |
55,662,220 |
55,665,752 |
RGD:6480464 |
CTD |
| G |
Rpl26 |
ribosomal protein L26 |
|
decreases expression |
ISO |
10 |
55,662,220 |
55,665,752 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
increases expression |
ISO |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rpl5l1 |
ribosomal protein L5-like 1 |
|
multiple interactions |
ISO |
9 |
113,233,164 |
113,234,057 |
RGD:6480464 |
CTD |
| G |
Rspo3 |
R-spondin 3 |
|
increases expression |
ISO |
1 |
29,072,171 |
29,156,096 |
RGD:6480464 |
CTD |
| G |
Rspo3 |
R-spondin 3 |
|
multiple interactions |
ISO |
1 |
29,072,171 |
29,156,096 |
RGD:6480464 |
CTD |
| G |
Senp6 |
SUMO1/sentrin specific peptidase 6 |
|
increases expression |
ISO |
8 |
85,123,804 |
85,183,953 |
RGD:6480464 |
CTD |
| G |
Senp6 |
SUMO1/sentrin specific peptidase 6 |
|
multiple interactions |
ISO |
8 |
85,123,804 |
85,183,953 |
RGD:6480464 |
CTD |
| G |
Sept7 |
septin 7 |
|
increases expression |
ISO |
8 |
24,924,747 |
24,988,221 |
RGD:6480464 |
CTD |
| G |
Sept7 |
septin 7 |
|
multiple interactions |
ISO |
8 |
24,924,747 |
24,988,221 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
multiple interactions |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
increases expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases activity |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
affects localization |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
affects metabolic processing |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
ISO |
1 |
232,469,746 |
232,549,584 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
multiple interactions |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc40a1 |
solute carrier family 40 (iron-regulated transporter), member 1 |
|
decreases expression |
ISO |
9 |
44,977,430 |
44,995,358 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases activity |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
increases expression |
ISO |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
multiple interactions |
ISO |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
decreases expression |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smad3 |
SMAD family member 3 |
|
multiple interactions |
ISO |
8 |
67,803,909 |
67,952,056 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
increases expression |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Smpd3 |
sphingomyelin phosphodiesterase 3, neutral membrane |
|
multiple interactions |
ISO |
19 |
36,112,166 |
36,195,564 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
affects response to substance |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
increases expression |
ISO |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
multiple interactions |
ISO |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Srp9 |
signal recognition particle 9 |
|
decreases expression |
ISO |
13 |
98,125,510 |
98,133,650 |
RGD:6480464 |
CTD |
| G |
Srp9 |
signal recognition particle 9 |
|
multiple interactions |
ISO |
13 |
98,125,510 |
98,133,650 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
increases expression |
ISO |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stip1 |
stress-induced phosphoprotein 1 |
|
multiple interactions |
ISO |
1 |
209,693,427 |
209,712,779 |
RGD:6480464 |
CTD |
| G |
Stx4 |
syntaxin 4 |
|
increases expression |
ISO |
1 |
187,125,847 |
187,132,932 |
RGD:6480464 |
CTD |
| G |
Stx4 |
syntaxin 4 |
|
multiple interactions |
ISO |
1 |
187,125,847 |
187,132,932 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
multiple interactions |
ISO |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
increases expression |
ISO |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Tfam |
transcription factor A, mitochondrial |
|
decreases expression |
ISO |
20 |
18,100,629 |
18,112,682 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
ISO |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
decreases expression |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
multiple interactions |
ISO |
7 |
19,677,144 |
19,727,072 |
RGD:6480464 |
CTD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
increases expression |
ISO |
8 |
34,966,856 |
34,969,727 |
RGD:6480464 |
CTD |
| G |
Tirap |
toll-interleukin 1 receptor (TIR) domain-containing adaptor protein |
|
multiple interactions |
ISO |
8 |
34,966,856 |
34,969,727 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
multiple interactions |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
increases expression |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
multiple interactions |
ISO |
5 |
25,008,253 |
25,014,263 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
multiple interactions |
ISO |
7 |
54,321,033 |
54,430,706 |
RGD:6480464 |
CTD |
| G |
Tph2 |
tryptophan hydroxylase 2 |
|
increases expression |
ISO |
7 |
54,321,033 |
54,430,706 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
increases expression |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
ISO |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
increases expression |
ISO |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Ubb |
ubiquitin B |
|
multiple interactions |
ISO |
10 |
139,578,694 |
139,579,068 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
decreases expression |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ubc |
ubiquitin C |
|
multiple interactions |
ISO |
12 |
32,333,211 |
32,337,944 |
RGD:6480464 |
CTD |
| G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
|
decreases expression |
ISO |
18 |
28,426,503 |
28,434,785 |
RGD:6480464 |
CTD |
| G |
Ube2d2 |
ubiquitin-conjugating enzyme E2D 2 |
|
multiple interactions |
ISO |
18 |
28,426,503 |
28,434,785 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
decreases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
multiple interactions |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
increases expression |
ISO |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Uros |
uroporphyrinogen III synthase |
|
decreases expression |
ISO |
1 |
193,184,946 |
193,205,475 |
RGD:6480464 |
CTD |
| G |
Uros |
uroporphyrinogen III synthase |
|
multiple interactions |
ISO |
1 |
193,184,946 |
193,205,475 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
multiple interactions |
ISO |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vps28 |
vacuolar protein sorting 28 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
7 |
114,670,491 |
114,674,339 |
RGD:6480464 |
CTD |
| G |
Vps28 |
vacuolar protein sorting 28 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
7 |
114,670,491 |
114,674,339 |
RGD:6480464 |
CTD |
| G |
Vps41 |
vacuolar protein sorting 41 homolog (S. cerevisiae) |
|
increases expression |
ISO |
17 |
53,893,474 |
54,063,005 |
RGD:6480464 |
CTD |
| G |
Vps41 |
vacuolar protein sorting 41 homolog (S. cerevisiae) |
|
multiple interactions |
ISO |
17 |
53,893,474 |
54,063,005 |
RGD:6480464 |
CTD |
| G |
Wbp4 |
WW domain binding protein 4 |
|
multiple interactions |
ISO |
15 |
61,517,401 |
61,543,453 |
RGD:6480464 |
CTD |
| G |
Wbp4 |
WW domain binding protein 4 |
|
increases expression |
ISO |
15 |
61,517,401 |
61,543,453 |
RGD:6480464 |
CTD |
| G |
Xbp1 |
X-box binding protein 1 |
|
decreases response to substance |
ISO |
14 |
86,151,910 |
86,156,975 |
RGD:6480464 |
CTD |
Term paths to the root
| Path 1 |
CHEBI ontology |
501881 |
 |
role |
491510 |
 |
biological role |
489686 |
 |
aetiopathogenetic role |
110697 |
 |
| neurotoxin |
82654 |
 |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
457 |
 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide |
0 |
 |
| Path 2 |
CHEBI ontology |
501881 |
 |
subatomic particle |
500845 |
 |
composite particle |
500845 |
 |
hadron |
500845 |
 |
baryon |
500845 |
 |
nucleon |
500845 |
 |
atomic nucleus |
500845 |
 |
atom |
500845 |
 |
main group element atom |
470301 |
 |
p-block element atom |
467779 |
 |
carbon group element atom |
419149 |
 |
carbon atom |
415667 |
 |
organic molecular entity |
415660 |
 |
organic molecule |
365810 |
 |
organic cyclic compound |
304492 |
 |
organic heterocyclic compound |
158510 |
 |
organic heteromonocyclic compound |
61261 |
 |
pyridines |
8224 |
 |
methylpyridines |
486 |
 |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
457 |
 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine N-oxide |
0 |
 |
| |
|